Trial Profile
A Phase III Randomized Controlled Study Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma (HCC) Treated With THYMITAQ to Patients Treated With Doxorubicin
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Nolatrexed (Primary) ; Doxorubicin
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms ETHECC
- Sponsors YM BioSciences USA
- 15 Aug 2005 New trial record.